The invention provides novel tricyclic compounds of Formula I′ that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.
[EN] COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES<br/>[FR] COMPOSÉS DE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
申请人:ARRAY BIOPHARMA INC
公开号:WO2012040641A2
公开(公告)日:2012-03-29
The invention provides novel tricyclic compounds of Formula I' that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.